Fineline Cube

Follow:
14409 Articles
Shanghai Junshi Biosciences' Toripalimab Wins UK Approval for Nasopharyngeal and Oesophageal Cancers
CompanyDrug

Shanghai Junshi Biosciences’ Toripalimab Wins UK Approval for Nasopharyngeal and Oesophageal Cancers

C-Ray Therapeutics Secures Over $100 Million in Series A+ Financing for Radiopharmaceuticals
CompanyDeals

C-Ray Therapeutics Secures Over $100 Million in Series A+ Financing for Radiopharmaceuticals

BioNTech Acquires Biotheus for $800 Million, Enhancing Oncology Pipeline
Company

BioNTech Acquires Biotheus for $800 Million, Enhancing Oncology Pipeline

Suzhou Ribo Life Science Receives EU Approval for Phase II Trial of RBD5044
Company

Suzhou Ribo Life Science Receives EU Approval for Phase II Trial of RBD5044

Ascentage Pharma Submits Application for Lisaftoclax, a Novel Oral Bcl-2 Inhibitor
CompanyDrug

Ascentage Pharma Submits Application for Lisaftoclax, a Novel Oral Bcl-2 Inhibitor

C-Ray Therapeutics Secures Over $100 Million in A+ Round Financing
Company

C-Ray Therapeutics Secures Over $100 Million in A+ Round Financing

lissBio Secures NMPA Approval for BB-1712, Pioneering ADC Therapy
CompanyDrug

Bliss Bio Secures NMPA Approval for BB-1712, Pioneering ADC Therapy

Merck KGaA Reports 3.8% Organic Growth in Q3 2024 Financials
Company

Merck KGaA Reports 3.8% Organic Growth in Q3 2024 Financials

Impact Therapeutics Secures $34.5 Million in Series D++ Financing for Senaparib Commercialization
CompanyDeals

Impact Therapeutics Secures $34.5 Million in Series D++ Financing for Senaparib Commercialization

GSK's Blenrep Shows Survival Benefit in Phase III Multiple Myeloma Study
CompanyDrug

GSK’s Blenrep Shows Survival Benefit in Phase III Multiple Myeloma Study

Janssen-Cilag's Nipocalimab Shows Promise in Phase II Study for Sjögren’s Disease
CompanyDrug

Janssen-Cilag’s Nipocalimab Shows Promise in Phase II Study for Sjögren’s Disease

Sanofi's Sarclisa Receives CHMP Recommendation for Newly Diagnosed Multiple Myeloma
CompanyDrug

Sanofi’s Sarclisa Receives CHMP Recommendation for Newly Diagnosed Multiple Myeloma